All Relations between dopaminergic and neurotransmitter

Publication Sentence Publish Date Extraction Date Species
Fatemeh Khakpai, Mohammad Nasehi, Ali Haeri-Rohani, Akram Eidi, Mohammad Reza Zarrindas. Septo-hippocampo-septal loop and memory formation. Basic and clinical neuroscience. vol 4. issue 1. 2014-10-22. PMID:25337323. the activity of septal and hippocampal neurons is modulated by several neurotransmitter systems including glutamatergic neurons from the entorhinal cortex, serotonergic fibers from the raphe nucleus, dopaminergic neurons from the ventral tegmental area (vta), histaminergic cells from the tuberomammillary nucleus and adrenergic fibers from the locus coeruleus (lc). 2014-10-22 2023-08-13 Not clear
Christopher Snyder, Kirk Mantion. The effects of morphine on Parkinson's-related genes PINK1 and PARK2. Medical science monitor basic research. vol 20. 2014-10-06. PMID:24800761. dopamine, the neurotransmitter produced from dopaminergic neurons, is a major precursor of endogenous morphine. 2014-10-06 2023-08-13 Not clear
Rudolph M Navar. Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting. European journal of pharmacology. vol 722. 2014-09-28. PMID:24157985. it blocks multiple neurotransmitter receptors including dopaminergic at d1, d2, d3, d4 brain receptors, serotonergic at 5-ht2a, 5-ht2c, 5-ht3, 5-ht6 receptors, catecholamines at alpha1 adrenergic receptors, acetylcholine at muscarinic receptors, and histamine at h1 receptors. 2014-09-28 2023-08-12 Not clear
Patricia J Allen, Andrew Feigi. Gene-based therapies in Parkinson's disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. vol 11. issue 1. 2014-09-19. PMID:24129887. parkinson's disease (pd) is a progressive neurological disorder characterized primarily by the degeneration of nigrostriatal dopaminergic neurons and diminution of the neurotransmitter dopamine. 2014-09-19 2023-08-12 human
Meghan R Hennis, Marian A Marvin, Charles M Taylor, Matthew S Goldber. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease. Neurobiology of disease. vol 62. 2014-09-03. PMID:24075852. the results of our behavioral, neurochemical and immunohistochemical analyses reveal that pd-linked mutations in parkin and dj-1 cause dysregulation of neurotransmitter systems beyond the nigrostriatal dopaminergic circuit and that loss-of-function mutations in parkin and dj-1 lead to adaptive changes in dopamine and serotonin especially in the context of gpx1 deficiency. 2014-09-03 2023-08-12 mouse
Erick T Tatro, Shannon Hefler, Stephanie Shumaker-Armstrong, Benchawanna Soontornniyomkij, Michael Yang, Alex Yermanos, Nina Wren, David J Moore, Cristian L Achi. Modulation of BK channel by MicroRNA-9 in neurons after exposure to HIV and methamphetamine. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 8. issue 5. 2014-08-18. PMID:23508624. our results suggest that hiv and ma -induced elevated mir-9, leading to suppression of mre-containing splice variants of kcnma1, which may affect neurotransmitter release in dopaminergic neurons. 2014-08-18 2023-08-12 human
Francesca Antonelli, Antonio P Strafell. Behavioral disorders in Parkinson's disease: the role of dopamine. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262157. in this review, we will summarize the possible proposed dopaminergic mechanisms responsible for these complications in pd, focusing mainly on the role of this neurotransmitter in behavioral symptoms. 2014-07-11 2023-08-12 Not clear
Janine Bayer, Pia Bandurski, Tobias Somme. Differential modulation of activity related to the anticipation of monetary gains and losses across the menstrual cycle. The European journal of neuroscience. vol 38. issue 10. 2014-07-08. PMID:23981052. estradiol and progesterone interact with the dopaminergic and other neurotransmitter systems that are involved in the processing of rewards. 2014-07-08 2023-08-12 Not clear
J G Rahol. Antidepressants: pharmacological profile and clinical consequences. International journal of psychiatry in clinical practice. vol 5. issue 1. 2014-06-19. PMID:24936991. three neurotransmitter systems are implicated in the biological basis of depression: the serotonergic system is thought to be a major component in the development of depression and in the efficacy of antidepressant drugs, while the noradrenergic and dopaminergic systems play lesser roles, but are important in the development of antidepressant side-effects. 2014-06-19 2023-08-13 Not clear
D Parkinson, A Spira, J P Wyse, M Patte. The ontogenesis of the dopaminergic cell in the pre- and postnatal guinea pig retina. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 3. issue 2. 2014-06-02. PMID:24874597. although a significant degree of development of the dopaminergic neurotransmitter system in the guinea pig occurs before birth the attainment of a fully mature system postnatally may require normal photic stimulation of physiologic activity. 2014-06-02 2023-08-13 Not clear
Sebastian Puschmann, André Brechmann, Christiane M Thie. Learning-dependent plasticity in human auditory cortex during appetitive operant conditioning. Human brain mapping. vol 34. issue 11. 2014-05-28. PMID:22610479. in addition, learners showed similar learning-induced differential responses to reward-predicting and nonreward-predicting tones in the ventral tegmental area and the nucleus accumbens, two core regions of the dopaminergic neurotransmitter system. 2014-05-28 2023-08-12 human
Prachi Kukshal, Venkat Chowdari Kodavali, Vibhuti Srivastava, Joel Wood, Lora McClain, Triptish Bhatia, A M Bhagwat, Smita Neelkanth Deshpande, Vishwajit Laxmikant Nimgaonkar, B K Thelm. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. Journal of psychiatric research. vol 47. issue 11. 2014-05-13. PMID:23932573. associations of polymorphisms from dopaminergic neurotransmitter pathway genes have mostly been reported in caucasian ancestry schizophrenia (sz) samples. 2014-05-13 2023-08-12 Not clear
Iñaki-Carril Mundiñano, Maria Hernandez, Carla Dicaudo, Cristina Ordoñez, Irene Marcilla, Maria-Teresa Tuñon, Maria-Rosario Luqui. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta neuropathologica. vol 126. issue 3. 2014-04-07. PMID:23784261. olfactory bulb (ob) pathology in these diseases shows an increased number of olfactory dopaminergic cells, protein aggregates and dysfunction of neurotransmitter systems. 2014-04-07 2023-08-12 human
Lars Brichta, Paul Greengard, Marc Flajole. Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems. Trends in neurosciences. vol 36. issue 9. 2014-04-02. PMID:23876424. novel pharmacological strategies must be optimized for pd by: (i) targeting disturbances of the serotonergic, noradrenergic, glutamatergic, gabaergic, and cholinergic systems in addition to the dopaminergic system, and (ii) characterizing alterations in the levels of neurotransmitter receptors and transporters that are associated with the various manifestations of the disease. 2014-04-02 2023-08-12 Not clear
Phillip L Pear. Monoamine neurotransmitter deficiencies. Handbook of clinical neurology. vol 113. 2014-03-27. PMID:23622404. there are therapeutic roles for neurotransmitter supplementation, and dopaminergic agonists. 2014-03-27 2023-08-12 Not clear
Jhodie Rubina Duncan, Andrew John Lawrenc. Conventional concepts and new perspectives for understanding the addictive properties of inhalants. Journal of pharmacological sciences. vol 122. issue 4. 2014-03-27. PMID:23883487. however, growing evidence suggests that the reinforcing properties of inhalants may also be driven by their ability to affect neurotransmitter systems other than the dopaminergic system. 2014-03-27 2023-08-12 Not clear
Yannick Vermeiren, Nathalie Le Bastard, An Van Hemelrijck, Wilhelmus H Drinkenburg, Sebastiaan Engelborghs, Peter P De Dey. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 9. issue 5. 2014-03-25. PMID:23159046. research suggests that altered activities of dopaminergic, serotonergic, (nor)adrenergic, as well as amino acid neurotransmitter systems play a role in the etiopathogenesis of bpsd. 2014-03-25 2023-08-12 Not clear
Romain Meeusen, Bart Roelands, Lawrence L Sprie. Caffeine, exercise and the brain. Nestle Nutrition Institute workshop series. vol 76. 2014-02-13. PMID:23899750. caffeine also has an effect on the central nervous system (cns), and it is now recognized that most of the performance-enhancing effect of caffeine is accomplished through the antagonism of the adenosine receptors, influencing the dopaminergic and other neurotransmitter systems. 2014-02-13 2023-08-12 Not clear
Peter R Joyce, John Stephenson, Martin Kennedy, Roger T Mulder, Patrick C McHug. The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder. Frontiers in genetics. vol 4. 2014-01-16. PMID:24432029. dysfunction in the dopaminergic and serotonergic neurotransmitter systems has been demonstrated to be important in the etiology of borderline personality disorder (bpd). 2014-01-16 2023-08-12 Not clear
Roger F Butterwort. Parkinsonism in cirrhosis: pathogenesis and current therapeutic options. Metabolic brain disease. vol 28. issue 2. 2013-12-16. PMID:23086199. the cause of parkinsonism in cirrhosis has been attributed to manganese deposition in basal ganglia structures, leading to the dysfunction of the dopaminergic neurotransmitter system. 2013-12-16 2023-08-12 Not clear